GlaxoSmithKline Pharmaceuticals Limited (BOM:500660)

BOM:500660 Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 3, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Market Capitalization	463,453	329,173	224,319	281,714	244,012	210,953
Market Cap Growth	18.69%	46.74%	-20.37%	15.45%	15.67%	-4.20%
Enterprise Value	442,492	313,334	211,499	270,099	237,483	201,694
Last Close Price	2735.75	1910.37	1272.88	1505.45	1279.15	1077.26
PE Ratio	53.95	55.80	36.73	16.62	68.13	226.33
Forward PE	47.43	44.16	35.58	42.30	40.93	39.19
PS Ratio	12.51	9.53	6.90	8.59	8.34	6.54
PB Ratio	28.15	18.52	12.88	10.58	16.51	11.59
P/TBV Ratio	23.06	18.77	13.14	10.72	17.01	11.91
P/FCF Ratio	59.76	50.96	36.30	45.72	63.05
P/OCF Ratio	56.56	46.33	34.75	42.22	43.01
PEG Ratio	3.10	6.49	1.44	2.17	2.36	2.41
EV/Sales Ratio	11.94	9.07	6.50	8.24	8.12	6.26
EV/EBITDA Ratio	40.54	35.58	26.83	36.36	41.42	31.37
EV/EBIT Ratio	42.91	37.35	28.26	38.65	45.71	34.36
EV/FCF Ratio	56.89	48.05	34.80	44.50	60.28
Debt / Equity Ratio	0.01	0.01	0.01	0.01	0.02	0.02
Debt / EBITDA Ratio	0.01	0.02	0.02	0.03	0.06	0.06
Debt / FCF Ratio	-	0.03	0.04	0.03	0.07	0.13
Asset Turnover	-	1.00	0.82	0.85	0.94	0.92
Inventory Turnover	-	2.75	2.62	2.55	2.49	2.73
Quick Ratio	-	1.45	1.50	1.83	1.02	1.17
Current Ratio	-	1.84	1.88	2.18	1.63	1.74
Return on Equity (ROE)	-	33.53%	27.59%	18.39%	17.42%	4.71%
Return on Assets (ROA)	-	15.24%	11.75%	11.28%	10.39%	10.42%
Return on Capital (ROIC)	39.68%	29.52%	21.07%	20.82%	19.24%	18.33%
Return on Capital Employed (ROCE)	-	41.30%	37.40%	23.80%	29.50%	27.80%
Earnings Yield	1.85%	1.79%	2.72%	6.02%	1.47%	0.44%
FCF Yield	1.67%	1.96%	2.76%	2.19%	1.59%
Dividend Yield	1.12%	1.68%	2.51%	1.99%	2.34%	1.86%
Payout Ratio	0.00%	91.80%	249.80%	29.89%	189.04%	363.51%
Total Shareholder Return	1.09%	1.68%	2.51%	1.99%	2.34%	1.86%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.